Basic Science Award recipient Alberto Ouro, PhD, presented his team’s cross-sectional study at the American Headache Society 68th Annual Scientific Meeting in Orlando, FL. The award recognizes the top basic...
In an Early Career Lecture Award study presented at the American Headache Society 68th Annual Scientific Meeting, nitroglycerin provoked headache and vestibular symptoms in participants with definite...
Recent studies in children and adults associate long COVID with worsened academic performance, attention difficulties, subjective cognitive impairment, and persistent neurologic and psychiatric symptoms.
...
The FDA has approved Avlayah (tividenofusp alfa-eknm) for certain pediatric patients with Hunter syndrome, marking the first approval targeting the disease's neurologic complications and offering clinicians...
The results from a recent randomized controlled trial showed that ultrasound-guided sphenopalatine ganglion (SPG) and greater occipital nerve blocks are equally effective in reducing headache frequency,...
In a recent study, exposure to fine particulate matter (PM2.5) was associated with both more advanced Alzheimer disease neuropathologic change and greater dementia severity, with much of this link mediated...
Researchers set out to determine whether attention-deficit/hyperactivity disorder predisposes individuals to the development of neuropsychiatric symptoms. The researchers presented their findings at the...
A large cohort study found no significant association between migraines, their subtypes, or frequency and Parkinson disease (PD) risk in women 45 years and older, suggesting migraines may not contribute to...
Brain age gap may be a potential biomarker for cognitive impairment, revealing that adults with sickle cell anemia and those from economically deprived backgrounds show signs of premature brain aging linked...
